常规超声与弹性成像作为自身免疫性肌炎影像学结局工具的系统综述
该研究由OMERACT超声组系统检索1973年至2019年文献,分析超声(含弹性成像)在自身免疫性肌炎中的度量学特性;纳入41篇全文、551例患者,发现标准效度和结构效度证据尚可,但判别力、信度和可行性报告不足,需标准化采集与进一步验证。
要点
- 超声在自身免疫性肌炎中显示一定的标准效度和结构效度证据。
- 仅1项纵向研究评估判别力,信度和可行性报告不足。
- 需统一采集标准化和目标域定义,并开展进一步验证研究。
核心结论
- 超声(含弹性成像)在自身免疫性肌炎中显示一定的标准效度和结构效度证据,可能是有前景的结局测量工具。
- 需就采集标准化和目标域定义达成共识,并进一步验证判别力、信度和可行性。
研究设计与样本
- 系统综述,采用PICO结构化检索Medline、Cochrane Library和Embase数据库,检索时间1973年1月1日至2019年8月5日。
- 纳入标准为涉及成人、英文发表、评估超声和弹性成像在自身免疫性肌炎中应用的原创研究;排除会议摘要和侧重技术而非超声域的计算机辅助诊断。
- 最终纳入41篇全文,共551例自身免疫性肌炎患者;18项研究(43.9%)有对照组,其中15项(63.3%)为健康对照。
主要发现
- 参与者(含对照)年龄18至86岁,多数为女性(59%)。
- 自身免疫性肌炎诊断大多经活检证实,部分基于临床表现、阳性临床影像和/或肌电图及激素反应性。
- 评估的超声特征包括肌肉回声性、体积、萎缩、结构、能量多普勒、灌注特征、剪切波模量、剪切波速度、弹性指数和肌束颤动。
- 12项研究(29.2%)使用定量方法评估上述特征,其余使用半定量、二分/二元和描述性评分系统。
- 标准效度在14项研究中达标(12/14,85.7%),结构效度在22项研究中达标(22/25,88.0%)。
关键数值与推荐
- 大多数发表文章报告证据等级为3b至5级,存在不同程度偏倚。
- 仅1项纵向研究评估判别力;信度和可行性报告不足。
临床怎么用
- 超声可作为自身免疫性肌炎结局测量的潜在工具,但需注意现有证据等级和偏倚。
- 临床应用中应关注标准化采集和目标域定义,并进一步验证判别力、信度和可行性。
局限性
- 大多数研究证据等级为3b至5级,存在不同程度偏倚。
- 仅1项纵向研究评估判别力,信度和可行性报告不足。
- 纳入研究间评估方法和评分系统异质,定量方法仅占29.2%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To analyze whether there is sufficient data from published literature to demonstrate that ultrasound, including elastography, present good metric properties (truth, discrimination and feasibility) in autoimmune myositis (AIM). METHODS: A population, intervention, comparator and outcome-structured (PICO) search was performed in Medline, Cochrane Library and Embase database from 01/01/1973 to 08/05/2019. The inclusion criteria required original research involving adult humans, reported in English, assessing ultrasound and elastography in patients with an AIM. Conference abstracts and computer-assisted diagnostics that focused on technique and not ultrasound domains were excluded. RESULTS: Approximately 2670 articles were identified. Forty-one full-text articles were included in the final analysis. There were 551 AIM patients studied. Eighteen studies (43.9%) had a control group, of which 15 (63.3%) were healthy controls. The age of participants (including controls) varied from 18 to 86 years, and most were females (59%). Diagnosis of AIM was largely biopsy-proven, although some were derived through clinical presentation, positive clinical imaging (ultrasound or otherwise) and/or electromyography and steroid responsiveness. The features examined with ultrasound in the 41 included articles consisted of: muscle echogenicity, bulk, atrophy, architecture, power Doppler, perfusion characteristics, shear wave modulus, shear wave velocity, elasticity index and fasciculations. Twelve studies (29.2%) used quantitative methods to assess these characteristics, whilst others used semi-quantitative, dichotomous/binary and descriptive scoring systems. Criterion validity was met in 14 studies (12/14, 85.7%) and construct validity in 22 studies (22/25, 88.0%). Most published articles reported Level 3b to Level 5 evidence with varying degrees of bias. There was only one longitudinal study examining discrimination. Reliability and feasibility were under-reported. CONCLUSION: This is the first systematic review studying the utility of ultrasound, including elastography, in AIM. There is some evidence for criterion and construct validity, suggesting that ultrasound may be a promising outcome measurement instrument in AIM. Agreement on the standardization of acquisition, and the definitions of target domains, is required. Additionally, further validation studies are required to determine discrimination, reliability and feasibility.
引用
- Paramalingam S, Morgan K, Becce F, et al. Conventional ultrasound and elastography as imaging outcome tools in autoimmune myositis: A systematic review by the OMERACT ultrasound group. Semin Arthritis Rheum. 2020. PMID: 33386164. doi:10.1016/j.semarthrit.2020.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。